Early Defensive Mechanisms against Human Papillomavirus Infection - Wikidata - awgldk - TriplyDB

Early Defensive Mechanisms against Human Papillomavirus Infection

Early Defensive Mechanisms against Human Papillomavirus Infection

http://www.wikidata.org/entity/Q26852611

about

Barriers to a cure for HIV in women Human beta-defensin 3 contributes to the carcinogenesis of cervical cancer via activation of NF-κB signaling.Immune evasion mechanisms of human papillomavirus: An update.Mouse papillomavirus infections spread to cutaneous sites with progression to malignancy.Mouse papillomavirus infection persists in mucosal tissues of an immunocompetent mouse strain and progresses to cancer.Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.Activities of stromal and immune cells in HPV-related cancers.New Insights in the Pathogenesis of HPV Infection and the Associated Carcinogenic Processes: The Role of Chronic Inflammation and Oxidative Stress

P2860

Q26768632-94910B08-04A3-4C5A-A7ED-C3665E3013DD Q37689038-EAAE2E9E-6868-4D81-B5FF-D82F0AD60109 Q40060642-0E91D51C-0BD5-49B9-880B-229E67807ED6 Q41931149-E2F010C8-8780-4117-96CF-C12CEA3F80BE Q47136512-0AE70A18-847B-4772-98A0-53ABDDB091B8 Q55003290-48231611-5B61-4883-9AED-4C5240C573C7 Q55507801-975990E6-50EB-4109-95AB-C3C626FBB3B8 Q58700402-0E34A948-823C-4C85-9D1B-ADC3E2EF577E

P2860

Early Defensive Mechanisms against Human Papillomavirus Infection

http://www.wikidata.org/entity/Q26852611

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Early Defensive Mechanisms against Human Papillomavirus Infection

@ast

Early Defensive Mechanisms against Human Papillomavirus Infection

@en

Early Defensive Mechanisms against Human Papillomavirus Infection

@nl

type

label

Early Defensive Mechanisms against Human Papillomavirus Infection

@ast

Early Defensive Mechanisms against Human Papillomavirus Infection

@en

Early Defensive Mechanisms against Human Papillomavirus Infection

@nl

prefLabel

Early Defensive Mechanisms against Human Papillomavirus Infection

@ast

Early Defensive Mechanisms against Human Papillomavirus Infection

@en

Early Defensive Mechanisms against Human Papillomavirus Infection

@nl

P1433

Q26852611-238D1E93-3EDA-42D0-8691-F24F95186BFF

P1476

Q26852611-0C980463-D719-4302-A7DE-2DE846F5195F

P2093

Q26852611-AEF41AA1-0C17-4195-996A-CDFF57C6C2C6

P2860

Q26852611-0174A84B-006A-4F88-BE16-E48246D34445

Q26852611-03BDF06A-3668-4AF7-BF99-23010D3E491B

Q26852611-055CCEE0-D8EF-47A6-B107-153AA97F5D31

Q26852611-073170DE-2E2B-4CAC-9124-D78BDEF2CD2D

Q26852611-07B33CDE-D388-4C30-BAD0-36D172DF051B

Q26852611-081180C6-9E95-4435-ADEA-29C7CAB32AFF

Q26852611-0C3D47F0-27BD-4545-8414-A6B2E0A7E3A4

Q26852611-0CE65E6A-C99A-4FF7-9C34-496931B4FBCB

Q26852611-0D06CB65-E3BC-48E1-9202-4F493E06862F

Q26852611-15D26AA3-366A-46F9-BEE0-2A38EA8D1945

P304

Q26852611-B23ED0E6-47E1-47EE-AB1A-E948EA95171C

P31

Q26852611-6994E872-3677-474D-9BD2-0A9BAAB2CCE2

P356

Q26852611-00A2A485-C4D8-4A13-81C5-5B8E8F6D85AE

P407

Q26852611-0714D6CA-66A8-45A2-B056-669E3530BAD5

P433

Q26852611-9F3E9B5C-C832-4C06-9027-5B09640BAEB8

P478

Q26852611-38823077-5706-418B-ADAE-91951065D658

P50

Q26852611-12069411-5CFD-4C17-AC40-D5414F34E317

P577

Q26852611-5C9A22B9-7A56-4732-B282-2F7794913613

P698

Q26852611-19657538-B642-4B99-AA66-567A51A2A6ED

P921

Q26852611-3347DB78-CB00-4E39-A49C-E2ABEDC37A6F

P932

Q26852611-B75F5AA9-DCF0-44B2-82A5-C9441F1C8E4A

P356

P1433

Clinical and Vaccine Immunology

P1476

Early Defensive Mechanisms against Human Papillomavirus Infection

@en

P2093

Andrea Moerman-Herzog

http://www.w3.org/2001/XMLSchema#string

P2860

Interferon-kappa, a novel type I interferon expressed in human keratinocytes

Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells

The causal relation between human papillomavirus and cervical cancer.

Therapy of human papillomavirus-related disease

Cancer-related inflammation

Papillomaviruses and cancer: from basic studies to clinical application

Type I interferons in host defense

Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway

Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels

A cell-based high-throughput assay for screening inhibitors of human papillomavirus-16 long control region activity.

P304

850-857

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00223-15

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Mayumi Nakagawa

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26063238

http://www.w3.org/2001/XMLSchema#string

P921

P932

4519724

http://www.w3.org/2001/XMLSchema#string